Study S001104

Semaglutide Therapy for Alcohol Reduction - Tulsa

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05891587
Acronym: STAR-T
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: COMPLETED
Enrollment: 80
Start: 2023-07-07
Primary completion: 2025-07-30
Lead sponsor: Oklahoma State University Center for Health Sciences
Conditions: Alcohol Use Disorder
Interventions: DRUG:Semaglutide; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Change in alcohol drinks per drinking day. [Baseline (Week 1) to post-medication (Week 13)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.